Mauro Zaccarelli
Mauro Zaccarelli
Dirigente Medico, INMI "Lazzaro Spallanzani, Roma
Email verificata su inmi.it
TitoloCitata daAnno
Combination antiretroviral therapy and the risk of myocardial infarction
Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group
New England Journal of Medicine 349 (21), 1993-2003, 2003
18722003
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
A Mocroft, B Ledergerber, C Katlama, O Kirk, P Reiss, AA Monforte, ...
The Lancet 362 (9377), 22-29, 2003
14552003
Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A: D study
S Collins, T Mertenskoetter, E Loeliger, R Tressler, I Weller, N Friis-M°ller, ...
Archives of internal medicine 166 (15), 1632-1641, 2006
12642006
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D: A: D study: a multi-cohort collaboration
D: A: D Study Group
The Lancet 371 (9622), 1417-1426, 2008
9582008
Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients
AA Monforte, AC Lepri, G Rezza, P Pezzotti, A Antinori, AN Phillips, ...
Aids 14 (5), 499-507, 2000
6412000
Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort
D Konopnicki, A Mocroft, S De Wit, F Antunes, B Ledergerber, C Katlama, ...
Aids 19 (6), 593-601, 2005
5972005
AIDS across Europe, 1994–98: the EuroSIDA study
A Mocroft, C Katlama, AM Johnson, C Pradier, F Antunes, F Mulcahy, ...
The Lancet 356 (9226), 291-296, 2000
5702000
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D: A: D): a multicohort collaboration
CJ Smith, L Ryom, R Weber, P Morlat, C Pradier, P Reiss, JD Kowalska, ...
The Lancet 384 (9939), 241-248, 2014
5692014
Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients
A Mocroft, O Kirk, P Reiss, S De Wit, D Sedlacek, M Beniowski, J Gatell, ...
Aids 24 (11), 1667-1678, 2010
4102010
Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study
A Mocroft, R Brettle, O Kirk, A Blaxhult, JM Parkin, F Antunes, P Francioli, ...
Aids 16 (12), 1663-1671, 2002
3692002
Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study.
LJD m L, Mocroft A, Kirk O, Worm SW, Kamara DA, Reiss P, Ross M, Fux CA ...
J Infect Dis 207 (9), 1359-69, 2013
2742013
Association Between Antiretroviral Exposure and Renal Impairment Among HIV-Positive Persons With Normal Baseline Renal Function: the D:A:D Studya
L Ryom, A Mocroft, O Kirk, SW Worm, DA Kamara, P Reiss, M Ross, ...
The Journal of infectious diseases 207 (9), 1359-1369, 2013
2742013
Influence of age on CD4 cell recovery in human immunodeficiency virus–infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study
JP Viard, A Mocroft, A Chiesi, O Kirk, B R°ge, G Panos, N Vetter, ...
The Journal of infectious diseases 183 (8), 1290-1294, 2001
2692001
Serious fatal and nonfatal non-AIDS-defining illnesses in Europe
A Mocroft, P Reiss, J Gasiorowski, B Ledergerber, J Kowalska, A Chiesi, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 55 (2), 262-270, 2010
2522010
Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America
Antiretroviral Therapy Cohort Collaboration
Clinical Infectious Diseases 41 (12), 1772-1782, 2005
2372005
Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study
JP Viard, JC Souberbielle, O Kirk, J Reekie, B Knysz, M Losso, J Gatell, ...
Aids 25 (10), 1305-1315, 2011
1942011
One-pill once-a-day HAART: a simplification strategy that improves adherence and quality of life of HIV-infected subjects
M Airoldi, M Zaccarelli, L Bisi, T Bini, A Antinori, C Mussini, F Bai, ...
Patient preference and adherence 4, 115, 2010
1922010
Risk factors for overdose mortality: a case-control study within a cohort of intravenous drug users
M DAVOLI, CA PERUCCI, F FORASTIERE, PAT DOYLE, E RAPITI, ...
International Journal of Epidemiology 22 (2), 273-277, 1993
1661993
A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survival
A Mocroft, S Madge, AM Johnson, A Lazzarin, N Clumeck, FD Goebel, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 22 (4), 369-378, 1999
1631999
Cross-resistance among nonnucleoside reverse transcriptase inhibitors limits recycling efavirenz after nevirapine failure
A Antinori, M Zaccarelli, A Cingolani, F Forbici, MG Rizzo, MP Trotta, ...
AIDS research and human retroviruses 18 (12), 835-838, 2002
1562002
Il sistema al momento non pu˛ eseguire l'operazione. Riprova pi¨ tardi.
Articoli 1–20